J. Foruny

Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?

E. de Vicente, G. Plaza, Y. Quijano, 2005, Gut.

Partial splenic embolization and peg‐IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long‐term outcome

J. Fortún, A. Moreno, J. Graus, 2009, Clinical transplantation.

Improved graft function in liver‐transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?

M. Rodríguez-Gandía, J. Fortún, A. Moreno, 2006, Clinical transplantation.

Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps.

Alberto Álvarez, Francisco Javier García-Alonso, Antonio Z. Gimeno-García, 2019, Gastroenterology.

Deranged smooth muscle α-actin expression as a biomarker of intestinal pseudo-obstruction

K. Gurusamy, J. Tweedie, Y. Quijano, 2005, Gut.

On Site Cytopatologist Assessment for Endosonography Guided Biopsy: Always, Never, On Demand?

E. Vazquez-Sequeiros, D. Juzgado, J. Milicua, 2006 .

Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.

A. Moreno, J. Blázquez, A. Moreno, 2006, Transplantation.

Do We Use More NGT than Needed?

A. Albillos, A. López San Román, J. Martínez-González, 2014, Digestive Diseases and Sciences.

Gastric polyps: analysis of endoscopic and histological features in our center.

E. Vazquez-Sequeiros, F. García-Alonso, J. R. Foruny, 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization

A. Muriel, C. Quereda, S. Moreno, 2005, European journal of gastroenterology & hepatology.